PL
CELG

Plancorp LLC’s Celgene Corp CELG Stock Holding History

Plancorp LLC’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,336
Closed -$232K – 193
2019
Q3 		$232K Hold
2,336
– – 0.09% 157
2019
Q2 		$216K Buy
2,336
+113
+5% +$10.7K 0.09% 161
2019
Q1 		$210K Buy
+2,223
New +$194K 0.08% 168
2018
Q1 		– Sell
-2,224
Closed -$233K – 173
2017
Q4 		$233K Sell
2,224
-500
-18% -$56.4K 0.08% 154
2017
Q3 		$397K Buy
+2,724
New +$371K 0.12% 105

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Plancorp LLC's CELG Position: Q4 2019 in Review

Plancorp LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,336 shares — an estimated $232K sold.

Plancorp LLC first reported a position in CELG in Q3 2017 and held it in 5 quarters. The position peaked at $397K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Plancorp LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Plancorp LLC sold 2,336 Celgene Corp shares in Q4 2019, an estimated $232K.
  • Plancorp LLC first reported a position in Celgene Corp in Q3 2017 and held it in 5 quarters.
  • Plancorp LLC's Celgene Corp position peaked at $397K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Plancorp LLC's 13F filing for Q4 2019, filed 3 Feb 2020.